| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |